You are here
Home > Interview

Sri City-gearing up for the new normal

Like Hosur on the Karnataka – Tamil Nadu border that attracted many industries, Sri City on the Andhra Pradesh – Tamil Nadu border, offering plug-and-play infrastrcuture, has evolved among the top 10 industrial clusters of India. Ravindra Sannareddy, like Apollo’s P C Reddy, exposed to the entrepreneurial expertise of the US, has built Sri City as an attractive place to locate a business. Sri City houses several multinationals – Kellog’s, Isuzu, Pepsi, Foxconn, Mondelex… In this interview, Sannareddy talks on how Sri City is reconfiguring its approach to move forward in a new normal world.

From Rs 300 crore to Rs 5000 crore

Multifaceted may, perhaps, be a proper description of B Santhanam (BS), Managing Director, Saint-Gobain India Private Limited (Flat Glass Business). Starting with a MoU on spending Rs 300 crore, SGIPL has invested over Rs 5000 crore in flat glass in India with manufacturing plants in Sriperumbudur (TN), Jhagadia (Gujarat), Bhiwadi (Rajasthan),

Advantage Tamil Nadu

Dr. T V Somanathan IAS, Additional Chief Secretary to Government - Planning, Development and Special Initiatives Department, Tamil Nadu, spoke to Industrial Economist on the state’s administrative strengths and fiscal prudence. INDUSTRIAL ECONOMIST (IE): What are the advantages that Tamil Nadu brings to the table? T V SOMANATHAN(TVS): First, our state’s administrative

Positive vibes from investors

Tamil Nadu is one of the few states that has a diversified industrial base and is unique because it has an exciting mix of power generation capacities in thermal, wind, nuclear, solar and even wave energy! For the second edition of Global Investors Meet scheduled in January, the Tamil Nadu government

Prathap C. Reddy continues to dream and dreams bolder…

When Apollo Hospitals commenced operations in 1983, it marked an important watershed: the first corporate hospital equipped with state-of-the art diagnostic equipment that are regularly updated. India is racing to become Number One in several non-communicable diseases; notably cardiac ailments, cancer, TB and diabetes. The incidence of these has been widespread